Who owns Spero Therapeutics Inc?
- Ticker: SPRO
- CUSIP Number: 84833t103
Tip: Access positions for across all investors
Analyze quarterly positions in Spero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Spero Therapeutics stock
Who bought or sold Spero Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Pfizer | 2.4M | $4.4M | 0% | Sep 2025 |
|
| Vanguard Group | 2.0M | $3.7M | 2% | Sep 2025 |
|
| Frigate Ventures | 1.6M | $3.0M | -1% | Sep 2025 |
|
| Renaissance Technologies | 1.5M | $2.7M | 75% | Sep 2025 |
|
| Alphabet | 890k | $1.7M | 0% | Sep 2025 |
|
| Geode Capital Management | 528k | $992k | 3% | Sep 2025 |
|
| BlackRock | 435k | $817k | 0% | Sep 2025 |
|
| Eudaimonia Asset Management | 282k | $531k | 18% | Sep 2025 |
|
| Ionic Capital Management | 209k | $392k | 39% | Sep 2025 |
|
| State Street Corporation | 191k | $359k | 24% | Sep 2025 |
|
| Arrowstreet Capital, Limited Partnership | 151k | $283k | 100% | Sep 2025 |
|
| Northern Trust | 130k | $244k | 29% | Sep 2025 |
|
| ADAR1 Capital Management | 116k | $217k | -20% | Sep 2025 |
|
| Bridgeway Capital Management | 115k | $216k | 0% | Sep 2025 |
|
| Intrepid Family Office | 110k | $207k | 100% | Sep 2025 |
|
| GSA Capital Partners | 107k | $201k | 100% | Sep 2025 |
|
| Shay Capital | 64k | $120k | 100% | Sep 2025 |
|
| Citadel Advisors | 55k | $103k | -77% | Sep 2025 |
|
| Two Sigma Investments | 49k | $93k | 100% | Sep 2025 |
|
| Jane Street | 43k | $81k | 100% | Sep 2025 |
|
| Cubist Systematic Strategies | 41k | $77k | 50% | Sep 2025 |
|
| American Century Companies | 40k | $76k | 100% | Sep 2025 |
|
| Assenagon Asset Management | 37k | $70k | 100% | Sep 2025 |
|
| XTX Topco | 34k | $64k | -2% | Sep 2025 |
|
| Capital Asset Advisory Services | 33k | $61k | 0% | Sep 2025 |
|
| Axxcess Wealth Management | 33k | $61k | 0% | Sep 2025 |
|
| Three Seasons Wealth | 30k | $56k | 0% | Sep 2025 |
|
| Rangeley Capital | 30k | $56k | 100% | Sep 2025 |
|
| Dimensional Fund Advisors | 29k | $55k | 100% | Sep 2025 |
|
| Charles Schwab Investment Management | 29k | $54k | 0% | Sep 2025 |
|
| UBS Group | 27k | $51k | 231% | Sep 2025 |
|
| Invesco | 22k | $42k | 48% | Sep 2025 |
|
| Group One Trading | 17k | $32k | 105% | Sep 2025 |
|
| Susquehanna International | 11k | $21k | -91% | Sep 2025 |
|
| Yale Capital Corp. | 10k | $19k | 0% | Sep 2025 |
|
| Morgan Stanley | 9.2k | $27k | 100% | Jun 2025 |
|
| Simplex Trading | 7.6k | $14k | -75% | Sep 2025 |
|
| FMR | 550.00 | $1.0k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 290.00 | $544.997000 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 236.00 | $444.010400 | -100% | Sep 2025 |
|
| Wells Fargo & Company | 200.00 | $376.000000 | 0% | Sep 2025 |
|
| Rockefeller Capital Management | 200.00 | $376.000000 | 100% | Sep 2025 |
|
| Us Bancorp | 151.00 | $284.000800 | 0% | Sep 2025 |
|
| Goss Wealth Management | 100.00 | $188.000000 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 40.00 | $75.000000 | 0% | Sep 2025 |
|
| SBI Securities | 10.00 | $19.000000 | -84% | Sep 2025 |
|
Who sold out of Spero Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Schonfeld Strategic Advisors | Jun 2025 | 511k | $1.5M |
| Monimus Capital Management | Jun 2025 | 311k | $902k |
| Stonepine Capital Management | Jun 2025 | 157k | $455k |
| Acadian Asset Management | Jun 2025 | 113k | $327k |
| EP Wealth Advisors | Mar 2025 | 17k | $12k |
| Royal Bank of Canada | Jun 2025 | 5.7k | $17k |
| Raymond James Financial | Jun 2025 | 3.1k | $8.9k |
| Cullen Frost Bankers | Jun 2025 | 2.0k | $5.8k |
| Tower Research Capital | Jun 2025 | 603.00 | $1.7k |